Rapid isolation of extracellular vesicles from stem cell conditioned medium using osmosis-driven filtration
Extracellular vesicles (EVs) hold significant promise as biomarkers and therapeutics, yet their isolation remains challenging due to their low abundance and complex sample matrices. Here, we introduce EV-Osmoprocessor (EVOs), a novel device that leverages osmosis-driven filtration for rapid and effi...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Science and Technology of Advanced Materials |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14686996.2025.2485668 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Extracellular vesicles (EVs) hold significant promise as biomarkers and therapeutics, yet their isolation remains challenging due to their low abundance and complex sample matrices. Here, we introduce EV-Osmoprocessor (EVOs), a novel device that leverages osmosis-driven filtration for rapid and efficient EV isolation. EVOs employs a high osmolarity polymer solution to concentrate EVs while simultaneously removing smaller contaminants. Compared to traditional methods such as ultracentrifugation and precipitation, EVOs offers speed and convenience, achieving a 50-fold volume reduction in under 2 h. Our results show that EVOs retained EVs and removed >99% albumin from the cell conditioned culture medium (CCM). The isolated EVs exhibited a particle size distribution centered around 140 nm, which was very similar to EVs isolated via precipitation or ultracentrifugation. The standalone EVOs process achieved a particle:protein ratio (EV purity) of ~107 particles/µg protein. Comprehensive characterization, including cryo-electron microscopy, validation of protein markers and known miRNA cargo confirmed the successful isolation of EVs. Functional assays, based on protection of cardiomyocytes from hypoxia/reoxygenation injury, demonstrated the bioactivity of EVOs-isolated EVs. Furthermore, we show that EVOs can be used to concentrate 30 ml of CCM into a 0.5 ml solution, which was then further processed with size-exclusion chromatography (SEC), improving EV purity to ~109 particles/µg protein. This work establishes EVOs as a promising tool for EV research and clinical applications, offering a streamlined approach to EV isolation with enhanced analytical performance. |
|---|---|
| ISSN: | 1468-6996 1878-5514 |